Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

Similar articles for PubMed (Select 21839482)

1.

Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.

Arnaoutakis GJ, George TJ, Kilic A, Weiss ES, Russell SD, Conte JV, Shah AS.

J Thorac Cardiovasc Surg. 2011 Nov;142(5):1236-45, 1245.e1. doi: 10.1016/j.jtcvs.2011.07.019. Epub 2011 Aug 11.

2.

Heart transplant graft survival is improved after a reduction in panel reactive antibody activity.

Schaffer JM, Singh SK, Reitz BA, Oyer PE, Robbins RC, Mallidi HR.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):555-64; discussion 564-5. doi: 10.1016/j.jtcvs.2012.10.025. Epub 2012 Dec 13. Erratum in: J Thorac Cardiovasc Surg. 2013 May;145(5):1419.

PMID:
23246047
3.

The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.

Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):169-73. doi: 10.1016/j.jtcvs.2010.03.026. Epub 2010 May 7.

PMID:
20451930
4.

Immunologic sensitization in recipients of left ventricular assist devices.

John R, Lietz K, Schuster M, Naka Y, Rao V, Mancini DM, Rose EA, Smith CR, Oz MC, Edwards NM, Itescu S.

J Thorac Cardiovasc Surg. 2003 Mar;125(3):578-91.

PMID:
12658200
5.

Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database.

Rossano JW, Morales DL, Zafar F, Denfield SW, Kim JJ, Jefferies JL, Dreyer WJ.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):694-9, 699.e1-2. doi: 10.1016/j.jtcvs.2010.04.009. Epub 2010 May 27.

PMID:
20537356
6.

Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.

Morris AA, Cole RT, Veledar E, Bellam N, Laskar SR, Smith AL, Gebel HM, Bray RA, Butler J.

J Am Coll Cardiol. 2013 Dec 17;62(24):2308-15. doi: 10.1016/j.jacc.2013.06.054. Epub 2013 Aug 28.

7.

Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.

Arnaoutakis GJ, George TJ, Kilic A, Beaty CA, Weiss ES, Conte JV, Shah AS.

Ann Thorac Surg. 2012 May;93(5):1549-54; discussion 1555. doi: 10.1016/j.athoracsur.2012.01.059. Epub 2012 Mar 17.

8.

HLA sensitization in ventricular assist device recipients: does type of device make a difference?

Kumpati GS, Cook DJ, Blackstone EH, Rajeswaran J, Abdo AS, Young JB, Starling RC, Smedira NG, McCarthy PM.

J Thorac Cardiovasc Surg. 2004 Jun;127(6):1800-7.

PMID:
15173739
9.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

PMID:
20447659
10.

Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.

Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV.

Ann Thorac Surg. 2007 Nov;84(5):1556-62; discussion 1562-3.

PMID:
17954062
11.

Panel reactive antibody monitoring in pediatric patients undergoing ventricle assist device as a bridge to heart transplantation.

Grutter G, Amodeo A, Brancaccio G, Parisi F.

Artif Organs. 2013 May;37(5):435-8. doi: 10.1111/aor.12016. Epub 2013 Feb 18.

PMID:
23419042
12.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.

Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):575-81. doi: 10.1016/j.jtcvs.2012.09.095.

PMID:
23321132
13.

Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.

Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund DG.

J Thorac Cardiovasc Surg. 2007 Jun;133(6):1612-9.

PMID:
17532964
14.

Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.

Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):566-73; discussion 573-4. doi: 10.1016/j.jtcvs.2012.10.034. Epub 2012 Dec 13.

15.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
16.

Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.

Asante-Korang A, Jacobs JP, Ringewald J, Carapellucci J, Rosenberg K, McKenna D, McCormack J, Wilmot I, Gjeldum A, Lopez-Cepero M, Sleasman J.

Cardiol Young. 2011 Dec;21 Suppl 2:124-32. doi: 10.1017/S1047951111001703. Review.

PMID:
22152539
17.

Is mechanically bridging patients with a failing cardiac graft to retransplantation an effective therapy? Analysis of the United Network of Organ Sharing database.

Khan MS, Mery CM, Zafar F, Adachi I, Heinle JS, Cabrera AG, Fraser CD Jr, Morales DL.

J Heart Lung Transplant. 2012 Nov;31(11):1192-8. doi: 10.1016/j.healun.2012.07.004. Epub 2012 Aug 17.

PMID:
22906499
18.

Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?

Massad MG, McCarthy PM, Smedira NG, Cook DJ, Ratliff NB, Goormastic M, Vargo RL, Navia J, Young JB, Stewart RW.

J Thorac Cardiovasc Surg. 1996 Nov;112(5):1275-81; discussion 1282-3.

PMID:
8911324
19.

Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?

Shuhaiber J, Hur K, Gibbons R.

J Card Surg. 2009 May-Jun;24(3):250-5. doi: 10.1111/j.1540-8191.2008.00794.x.

PMID:
19438776
20.

Combined heart-kidney transplant improves post-transplant survival compared with isolated heart transplant in recipients with reduced glomerular filtration rate: Analysis of 593 combined heart-kidney transplants from the United Network Organ Sharing Database.

Karamlou T, Welke KF, McMullan DM, Cohen GA, Gelow J, Tibayan FA, Mudd JM, Slater MS, Song HK.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):456-461.e1. doi: 10.1016/j.jtcvs.2013.09.017. Epub 2013 Oct 31.

PMID:
24183335
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk